I have finalised the demo for the ICH-GCP E6 R3 refresher course. Overall, I liked the content and the interface. I also want to thank Whitehall Train...
About
Pharmaceutical change control is a fundamental element of the Pharmaceutical Quality System (PQS), ensuring that planned changes are evaluated, approved, implemented, and monitored without compromising product quality, patient safety, or regulatory compliance. Effective product lifecycle management integrates scientific knowledge, quality risk management, continual improvement, and regulatory oversight to support products from development through commercial manufacture and discontinuation.
This QA – Pharmaceutical Change Control and Product Lifecycle Management Training Course & Certification provides comprehensive knowledge of change control principles, change classification, impact and risk assessment, cross-functional governance, validation and qualification impacts, comparability assessments, technology transfer, post-approval changes, effectiveness verification, lifecycle management, regulatory expectations, documentation, inspection readiness, and continual improvement within pharmaceutical quality systems. Upon successful completion, learners receive a certification demonstrating their understanding of pharmaceutical change control and product lifecycle management best practices.
- Quality Assurance and Quality Management Professionals
- Manufacturing, Production, and Operations Personnel
- Validation, Engineering, and Technical Services Professionals
- Regulatory Affairs and CMC Professionals
- Quality Control and Laboratory Personnel
- Process Development and Technology Transfer Teams
- Internal Auditors and Continuous Improvement Specialists
- Anyone involved in change control, product lifecycle management, or pharmaceutical quality systems
What you will learn
Understand the principles of pharmaceutical change control, product lifecycle management, regulatory expectations, and the role of effective change management in maintaining product quality and compliance.
Learn how to initiate, classify, assess, approve, implement, and verify changes using risk-based methodologies while evaluating quality, regulatory, validation, and supply chain impacts.
Develop knowledge of cross-functional change management, comparability assessments, technology transfer, post-approval changes, continual improvement, and lifecycle knowledge management.
Gain practical understanding of change control documentation, effectiveness verification, regulatory submissions, inspection readiness, metrics, governance, and best practices for managing product lifecycle changes.
Course Syllabus
- What is change control?
- Change control vs deviation vs CAPA
- Why changes require governance
- The product lifecycle
- Where change control sits
- Sources of change
- Four types of change
- Temporary changes — extra controls
- Emergency changes — controlled, not exempt
- Internal change vs regulatory change
- Change ownership and accountability
- PQS and knowledge management
- Quality risk management in change
- Change-control system interfaces
- Exercise — system-interface mapping
- Anatomy of a good change proposal
- Current state vs proposed state
- Business and quality rationale
- Defining scope precisely
- Classification — categories differ
- Criticality and urgency are different
- Emergency change — entering the system
- Duplicate and linked changes
- Ownership, routing and governance
- Rejection and return — with rationale
- Workshop — proposal writing
- Orion — classification & routing
- Start with product quality and patient impact
- Validation and qualification impact
- Computerised systems and data integrity
- Facilities, utilities and equipment
- Materials, suppliers, methods and stability
- Cleaning, contamination control and training
- Clinical, safety, regulatory and supply
- EHS and cybersecurity
- Applying proportionate QRM
- FMEA in brief
- Exercise — FMEA on Orion's software upgrade
- Cross-functional review simulation
- Preventing unintended consequences
- Variations and supplements
- Reporting categories
- EU and UK frameworks — current position
- US framework — 21 CFR 314.70
- ICH Q12 — established conditions
- PACMP and the PLCM document
- Global market differences
- Submission sequencing and dependencies
- Artwork, labelling and implementation dates
- Communication with authorities
- Orion — regulatory impact
- Exercise — submission dependency map
- The implementation plan
- Documents, training and readiness
- Qualification and validation
- Comparability and stability
- Inventory disposition
- Cutover control
- Rollback and contingency
- Post-implementation monitoring
- Effectiveness criteria and verification
- Closure evidence
- Orion — implementation & effectiveness
- Change review boards
- Quality-unit oversight
- Extensions, linked deviations and CAPA
- Repeat and failed changes
- Metrics that reveal programme health
- Reading metrics — interpretation
- Management review and PQR
- Inspection readiness
- Integrated final case — Orion
- Exercises — board, metrics, mock inspection
- 📘 Bonus:Pharmaceutical Change Control and Product Lifecycle Management eBook (Free with purchase)
Course Benefits

Get our exclusive eBook with every purchase - a complete companion guide to the course, yours to keep forever
Gain Continuing Professional Development (CPD) Points, accredited by The Faculty of Pharmaceutical Medicine of the Royal College of Physicians of the United Kingdom. These can be used to count towards the distance learning element of any scheme that comes under the umbrella of The Academy of Medical Royal Colleges or any other scheme for which there is mutual recognition.
Receive a personal certificate to show your subject knowledge on course completion.
You get excellent value through our cost-effective prices. We can also offer you group discounts on larger purchases.
The course saves you time through the convenience of online availability. This lets you complete the interactive course at your own comfort.
You will stay aligned with current effective texts including ICH Q10, ICH Q9(R1) and ICH Q12, EudraLex Volume 4 Chapter 1 and Annex 15, the EU variations framework (Regulation (EC) No 1234/2008 as amended by Regulation (EU) 2024/1701, with revised Variations Guidelines applying from January 2026), FDA 21 CFR 314.70, and current MHRA variation and data-integrity guidance. Draft or consultation material is clearly flagged.
Content reflects the combined practice of change-control system owners, validation specialists, regulatory CMC professionals and quality-risk-management practitioners, expressed through worked examples and an integrated case study.






